Skip to main content
. 2023 Jul 4;16(9):1691–1703. doi: 10.1111/cts.13580

TABLE 4.

GFH312 PK parameters postdose on day 1 and day 14 in part II.

GFH312 GFH312 GFH312
60 mg q.d. (N = 6) 120 mg q.d. (N = 7) 200 mg q.d. (N = 6)
Day 1, geomean (geoCV%)
C max (ng/mL) 587.7 (61.0) 587.8 (63.1) 946.1 (47.9)
T max (h) a 4.0 (4.0–4.1) 4.0 (2.0–23.7) 4.1 (2.0–8.3)
AUC0–t (h ng/mL) 7770.9 (50.4) 8473.9 (40.9) 13,031.9 (35.1)
Day 14, geomean (geoCV%)
C max,ss (ng/mL) 738.0 (22.5) b 921.7 (28.3) c 1290.2 (29.0) e
C min,ss (ng/mL) 249.3 (51.3) b 362.8 (32.6) c 543.6 (33.5) e
T max,ss (h) a 4.0 (1.0–4.1) b 2.0 (2.0–3.9) c 4.0 (2.0–4.0) e
AUC0–tau (h ng/mL) 10,656.5 (34.4) b 12,973.5 (24.1) c 18,963.7 (30.6) e
RAAUC 1.3 (39.3) b 1.3 (55.2) d 1.6 (35.2) f
RACmax 1.1 (47.4) b 1.5 (62.4) c 1.2 (45.8) e

Abbreviations: AUC0–t , area under the drug concentration‐time curve from time zero to the last quantifiable concentration; AUC0–tau, area under the drug concentration‐time curve from time zero to end of dosing period; AUC0–24, area under the drug concentration‐time curve from time zero to 24 h; C max, maximum concentration; C max,ss, maximum concentration at steady‐state; C min,ss, minimum concentration at steady‐state; geoCV%, geometric coefficient of variation; geomean, geometric mean; PK, pharmacokinetic; QD, once daily; RAAUC, accumulation ratio calculated by AUC; RACmax, accumulation ratio calculated by C max; T max, time to maximum concentration; T max,ss, time to maximum concentration at steady‐state.

a

T max and T max,ss are reported as median (range).

b

n = 5, one subject discontinued treatment on day 7 due to adverse event.

c

n = 6, one subject discontinued treatment on day 12 due to personal reasons.

d

n = 5, one subject discontinued treatment on day 12 due to personal reasons, and for another subject, AUC0–24 on day 1 and RAAUC could not be calculated.

e

n = 5, one subject discontinued treatment on day 8 due to an adverse event.

f

n = 3, for three subjects, AUC0–24 on day 1 and RAAUC could not be calculated.